Literature DB >> 15128788

The role of the p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and phosphoinositide-3-OH kinase signal transduction pathways in CD40 ligand-induced dendritic cell activation and expansion of virus-specific CD8+ T cell memory responses.

Qigui Yu1, Colin Kovacs, Feng Yun Yue, Mario A Ostrowski.   

Abstract

Mature dendritic cells (DCs) are central to the development of optimal T cell immune responses. CD40 ligand (CD40L, CD154) is one of the most potent maturation stimuli for immature DCs. We studied the role of three signaling pathways, p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase (ERK), and phosphoinositide-3-OH kinase (PI3K), in CD40L-induced monocyte-derived DC activation, survival, and expansion of virus-specific CD8(+) T cell responses. p38 MAPK pathway was critical for CD40L-mediated up-regulation of CD83, a marker of DC maturation. CD40L-induced monocyte-derived DC IL-12 production was mediated by both the p38 MAPK and PI3K pathways. CD40L-mediated DC survival was mostly mediated by the PI3K pathway, with smaller contributions by p38 MAPK and ERK pathways. Finally, the p38 MAPK pathway was most important in mediating CD40L-stimulated DCs to induce strong allogeneic responses as well as expanding virus-specific memory CD8(+) T cell responses. Thus, although the p38 MAPK, PI3K, and ERK pathways independently affect various parameters of DC maturation induced by CD40L, the p38 MAPK pathway within CD40L-conditioned DCs is the most important pathway to maximally elicit T cell immune responses. This pathway should be exploited in vivo to either completely suppress or enhance CD8(+) T cell immune responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128788     DOI: 10.4049/jimmunol.172.10.6047

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

Review 1.  Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances.

Authors:  Gwendalyn J Randolph; Guzman Sanchez-Schmitz; Veronique Angeli
Journal:  Springer Semin Immunopathol       Date:  2005-01

2.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.

Authors:  Jianguo Liu; Shanjin Cao; Sunjung Kim; Elaine Y Chung; Yoichiro Homma; Xiuqin Guan; Violeta Jimenez; Xiaojing Ma
Journal:  Curr Immunol Rev       Date:  2005-06

Review 3.  Transcription factors in the control of dendritic cell life cycle.

Authors:  Arpita S Bharadwaj; Devendra K Agrawal
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 4.  Molecular mechanism and function of CD40/CD40L engagement in the immune system.

Authors:  Raul Elgueta; Micah J Benson; Victor C de Vries; Anna Wasiuk; Yanxia Guo; Randolph J Noelle
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

5.  p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression.

Authors:  Yong Lu; Mingjun Zhang; Siqing Wang; Bangxing Hong; Zhiqiang Wang; Haiyan Li; Yuhuan Zheng; Jing Yang; Richard E Davis; Jianfei Qian; Jian Hou; Qing Yi
Journal:  Nat Commun       Date:  2014-06-24       Impact factor: 14.919

Review 6.  Cell Signaling Pathways That Regulate Antigen Presentation.

Authors:  Randy R Brutkiewicz
Journal:  J Immunol       Date:  2016-10-15       Impact factor: 5.422

7.  1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity.

Authors:  Sophie Agaugué; Laure Perrin-Cocon; Frédéric Coutant; Patrice André; Vincent Lotteau
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

8.  Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial).

Authors:  Elena Chernykh; Olga Leplina; Ekaterina Oleynik; Marina Tikhonova; Tamara Tyrinova; Natalia Starostina; Alexandr Ostanin
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

9.  Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine.

Authors:  Ming-Cheng Chang; Yu-Li Chen; Ying-Cheng Chiang; Ya-Jung Cheng; Yu-Wei Jen; Chi-An Chen; Wen-Fang Cheng; Wei-Zen Sun
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

10.  Nocardia farcinica activates human dendritic cells and induces secretion of interleukin-23 (IL-23) rather than IL-12p70.

Authors:  Martin Eisenblätter; Ariane Buchal; Hermine Gayum; Edith Jasny; Pablo Renner Viveros; Timo Ulrichs; Thomas Schneider; Ralf R Schumann; Janine Zweigner; Ralf Ignatius
Journal:  Infect Immun       Date:  2012-09-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.